

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 9.38208012 |
| 2 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 9.38208012 |
| 3 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 9.23686297 |
| 4 | glycine transport (GO:0015816) | 8.94736193 |
| 5 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 8.12319198 |
| 6 | response to water (GO:0009415) | 7.94896583 |
| 7 | positive regulation of fibroblast migration (GO:0010763) | 7.88863141 |
| 8 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 7.54656538 |
| 9 | hematopoietic stem cell proliferation (GO:0071425) | 7.47384418 |
| 10 | regulation of hair follicle development (GO:0051797) | 7.40128265 |
| 11 | detection of calcium ion (GO:0005513) | 7.36075811 |
| 12 | L-amino acid import (GO:0043092) | 7.28088220 |
| 13 | NAD biosynthetic process (GO:0009435) | 7.23885319 |
| 14 | inner ear receptor cell development (GO:0060119) | 6.44662424 |
| 15 | centriole assembly (GO:0098534) | 6.42681492 |
| 16 | superoxide anion generation (GO:0042554) | 6.31028357 |
| 17 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 5.99737683 |
| 18 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 5.88476594 |
| 19 | pyridine nucleotide biosynthetic process (GO:0019363) | 5.88476594 |
| 20 | reflex (GO:0060004) | 5.79798107 |
| 21 | exogenous drug catabolic process (GO:0042738) | 5.78636513 |
| 22 | skeletal muscle fiber development (GO:0048741) | 5.75168619 |
| 23 | amino acid import (GO:0043090) | 5.59835333 |
| 24 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.28469397 |
| 25 | cellular response to vitamin D (GO:0071305) | 5.18210210 |
| 26 | response to hepatocyte growth factor (GO:0035728) | 5.17555659 |
| 27 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 5.17555659 |
| 28 | regulation of DNA-templated transcription, initiation (GO:2000142) | 4.99673878 |
| 29 | pyridine-containing compound biosynthetic process (GO:0072525) | 4.89809431 |
| 30 | response to lipoprotein particle (GO:0055094) | 4.83035117 |
| 31 | regulation of hair cycle (GO:0042634) | 4.78023250 |
| 32 | myoblast differentiation (GO:0045445) | 4.77502547 |
| 33 | myotube cell development (GO:0014904) | 4.75127832 |
| 34 | drug catabolic process (GO:0042737) | 4.71408499 |
| 35 | regulation of RIG-I signaling pathway (GO:0039535) | 4.41044379 |
| 36 | response to gravity (GO:0009629) | 4.40079190 |
| 37 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 4.31102883 |
| 38 | skeletal muscle contraction (GO:0003009) | 4.27923599 |
| 39 | chemosensory behavior (GO:0007635) | 4.06562430 |
| 40 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 3.94957935 |
| 41 | phosphorelay signal transduction system (GO:0000160) | 3.81217627 |
| 42 | neurotransmitter biosynthetic process (GO:0042136) | 3.80968790 |
| 43 | trabecula formation (GO:0060343) | 3.80297959 |
| 44 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.70631070 |
| 45 | cAMP catabolic process (GO:0006198) | 3.64665048 |
| 46 | NAD metabolic process (GO:0019674) | 3.64026680 |
| 47 | RNA-dependent DNA replication (GO:0006278) | 3.59529945 |
| 48 | cellular response to vitamin (GO:0071295) | 3.57950393 |
| 49 | sensory perception of taste (GO:0050909) | 3.57390138 |
| 50 | homocysteine metabolic process (GO:0050667) | 3.55805895 |
| 51 | positive regulation of osteoblast proliferation (GO:0033690) | 3.52228635 |
| 52 | diacylglycerol metabolic process (GO:0046339) | 3.50094653 |
| 53 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 3.48938119 |
| 54 | positive regulation of calcium ion import (GO:0090280) | 3.44308205 |
| 55 | telomere maintenance via telomerase (GO:0007004) | 3.36282848 |
| 56 | DNA integration (GO:0015074) | 3.34199291 |
| 57 | positive regulation of epidermis development (GO:0045684) | 3.34198078 |
| 58 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.31668721 |
| 59 | cyclic nucleotide catabolic process (GO:0009214) | 3.25725010 |
| 60 | negative regulation of myoblast differentiation (GO:0045662) | 3.24813897 |
| 61 | regulation of cell cycle G2/M phase transition (GO:1902749) | 3.22611550 |
| 62 | superoxide metabolic process (GO:0006801) | 3.19776964 |
| 63 | positive regulation of response to biotic stimulus (GO:0002833) | 3.13591747 |
| 64 | regulation of synapse maturation (GO:0090128) | 3.09360997 |
| 65 | detection of mechanical stimulus (GO:0050982) | 3.08615409 |
| 66 | negative regulation of protein localization to cell surface (GO:2000009) | 3.01640637 |
| 67 | multicellular organism reproduction (GO:0032504) | 3.00664523 |
| 68 | protein localization to microtubule (GO:0035372) | 2.97938951 |
| 69 | arginine catabolic process (GO:0006527) | 2.96081028 |
| 70 | eye photoreceptor cell differentiation (GO:0001754) | 2.94562560 |
| 71 | photoreceptor cell differentiation (GO:0046530) | 2.94562560 |
| 72 | activated T cell proliferation (GO:0050798) | 2.92955985 |
| 73 | regulation of fibroblast migration (GO:0010762) | 2.90727216 |
| 74 | chondrocyte differentiation (GO:0002062) | 2.90626264 |
| 75 | glomerulus development (GO:0032835) | 2.88407234 |
| 76 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.88095344 |
| 77 | tryptophan metabolic process (GO:0006568) | 2.84382632 |
| 78 | kynurenine metabolic process (GO:0070189) | 2.84268714 |
| 79 | positive regulation of bone mineralization (GO:0030501) | 2.79041948 |
| 80 | nephron tubule formation (GO:0072079) | 2.75464461 |
| 81 | cellular response to cAMP (GO:0071320) | 2.75355939 |
| 82 | lysine metabolic process (GO:0006553) | 2.72694844 |
| 83 | lysine catabolic process (GO:0006554) | 2.72694844 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 2.72519269 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 2.72519269 |
| 86 | tryptophan catabolic process (GO:0006569) | 2.72519269 |
| 87 | inositol phosphate-mediated signaling (GO:0048016) | 2.71074561 |
| 88 | meiotic chromosome segregation (GO:0045132) | 2.69472754 |
| 89 | negative regulation of neurotransmitter transport (GO:0051589) | 2.64918368 |
| 90 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.63720162 |
| 91 | ruffle organization (GO:0031529) | 2.61754397 |
| 92 | positive regulation of mitotic cell cycle phase transition (GO:1901992) | 2.61186717 |
| 93 | negative regulation of telomere maintenance (GO:0032205) | 2.59339935 |
| 94 | positive regulation of cell cycle phase transition (GO:1901989) | 2.58934682 |
| 95 | positive regulation of biomineral tissue development (GO:0070169) | 2.57388295 |
| 96 | detection of chemical stimulus (GO:0009593) | 2.55833004 |
| 97 | bone trabecula formation (GO:0060346) | 12.0442059 |
| 98 | response to parathyroid hormone (GO:0071107) | 11.6227649 |
| 99 | positive regulation of hair cycle (GO:0042635) | 10.5774500 |
| 100 | positive regulation of hair follicle development (GO:0051798) | 10.5774500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.08025751 |
| 2 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.55148160 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27368601 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.87362815 |
| 5 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.59123874 |
| 6 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.37577056 |
| 7 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.22272188 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19403431 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.17605247 |
| 10 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.07613169 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.01293261 |
| 12 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.98897040 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.93980125 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.85504673 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74710307 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.73564101 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.73564101 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72563479 |
| 19 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.72214074 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.71358472 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70487349 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.70204727 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.66924075 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66110538 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65840951 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65805282 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64414987 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.62931469 |
| 29 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.61378322 |
| 30 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.61206778 |
| 31 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.58515805 |
| 32 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.58188551 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57550640 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57496918 |
| 35 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52532304 |
| 36 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.51903230 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.51831685 |
| 38 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.50952284 |
| 39 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.50942926 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47981993 |
| 41 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.45197595 |
| 42 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.44500260 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.43035076 |
| 44 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.42376451 |
| 45 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.41548447 |
| 46 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.41147304 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41061787 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.40772351 |
| 49 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.40303946 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39707123 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.32865341 |
| 52 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.32273768 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.31030080 |
| 54 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.30655273 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30185048 |
| 56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28564839 |
| 57 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27268035 |
| 58 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.27013141 |
| 59 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.26207321 |
| 60 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.25337581 |
| 61 | KDM2B_26808549_Chip-Seq_REH_Human | 1.24401487 |
| 62 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.23893974 |
| 63 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.22806731 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22479209 |
| 65 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.21401017 |
| 66 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.21108539 |
| 67 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.17432097 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17414262 |
| 69 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.17193380 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17159488 |
| 71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15742957 |
| 72 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14860106 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09683921 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06813685 |
| 75 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06158145 |
| 76 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06081771 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03995924 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03141912 |
| 79 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.00447873 |
| 80 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00403755 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00313752 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99239606 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.98627873 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95751030 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95439717 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94716319 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94256885 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94114750 |
| 89 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94051501 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93854034 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93432477 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93238277 |
| 93 | TBL1_22424771_ChIP-Seq_293T_Human | 0.92439378 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91426318 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91005923 |
| 96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.90303228 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90076746 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89931069 |
| 99 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89500224 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86810253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 8.49739961 |
| 2 | MP0003195_calcinosis | 8.10894393 |
| 3 | MP0001188_hyperpigmentation | 3.54595293 |
| 4 | MP0000750_abnormal_muscle_regeneration | 3.23587706 |
| 5 | MP0009384_cardiac_valve_regurgitation | 3.11748981 |
| 6 | MP0005451_abnormal_body_composition | 2.97642314 |
| 7 | MP0004484_altered_response_of | 2.80348959 |
| 8 | MP0008057_abnormal_DNA_replication | 2.59880374 |
| 9 | MP0006072_abnormal_retinal_apoptosis | 2.55600468 |
| 10 | MP0004142_abnormal_muscle_tone | 2.52068666 |
| 11 | MP0004782_abnormal_surfactant_physiolog | 2.48366758 |
| 12 | MP0005410_abnormal_fertilization | 2.48101827 |
| 13 | MP0000678_abnormal_parathyroid_gland | 2.45591080 |
| 14 | MP0009764_decreased_sensitivity_to | 2.30523963 |
| 15 | MP0000579_abnormal_nail_morphology | 2.28902829 |
| 16 | MP0003283_abnormal_digestive_organ | 2.28736501 |
| 17 | MP0003646_muscle_fatigue | 2.25698229 |
| 18 | MP0005623_abnormal_meninges_morphology | 2.20136309 |
| 19 | MP0003941_abnormal_skin_development | 2.19347863 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.16455235 |
| 21 | MP0004858_abnormal_nervous_system | 2.11279459 |
| 22 | MP0002168_other_aberrant_phenotype | 1.99845088 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 1.91691107 |
| 24 | MP0009785_altered_susceptibility_to | 1.83872737 |
| 25 | MP0004742_abnormal_vestibular_system | 1.83280760 |
| 26 | MP0002736_abnormal_nociception_after | 1.79945184 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.79648189 |
| 28 | MP0001486_abnormal_startle_reflex | 1.69018659 |
| 29 | MP0009697_abnormal_copulation | 1.66154869 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.65442187 |
| 31 | MP0005165_increased_susceptibility_to | 1.50015206 |
| 32 | MP0003122_maternal_imprinting | 1.47933736 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.44939116 |
| 34 | MP0004859_abnormal_synaptic_plasticity | 1.33992105 |
| 35 | MP0002108_abnormal_muscle_morphology | 1.31062249 |
| 36 | MP0004043_abnormal_pH_regulation | 1.29657530 |
| 37 | MP0000733_abnormal_muscle_development | 1.29603656 |
| 38 | MP0000383_abnormal_hair_follicle | 1.27315660 |
| 39 | MP0003123_paternal_imprinting | 1.26059316 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.18289535 |
| 41 | MP0003045_fibrosis | 1.12680989 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.11505084 |
| 43 | MP0001968_abnormal_touch/_nociception | 1.11480605 |
| 44 | MP0000490_abnormal_crypts_of | 1.06404877 |
| 45 | MP0009745_abnormal_behavioral_response | 1.02145555 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.00372713 |
| 47 | MP0003121_genomic_imprinting | 0.97997392 |
| 48 | MP0001502_abnormal_circadian_rhythm | 0.97496232 |
| 49 | MP0001440_abnormal_grooming_behavior | 0.96969952 |
| 50 | MP0002067_abnormal_sensory_capabilities | 0.95537863 |
| 51 | MP0008874_decreased_physiological_sensi | 0.93355196 |
| 52 | MP0003075_altered_response_to | 0.92088065 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 0.91695250 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 0.89832913 |
| 55 | MP0005253_abnormal_eye_physiology | 0.89450090 |
| 56 | MP0005387_immune_system_phenotype | 0.89109618 |
| 57 | MP0001790_abnormal_immune_system | 0.89109618 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 0.88332569 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 0.87662390 |
| 60 | MP0002419_abnormal_innate_immunity | 0.85253805 |
| 61 | MP0005369_muscle_phenotype | 0.84706494 |
| 62 | MP0005395_other_phenotype | 0.78061290 |
| 63 | MP0002184_abnormal_innervation | 0.70660232 |
| 64 | MP0002396_abnormal_hematopoietic_system | 0.70316654 |
| 65 | MP0005360_urolithiasis | 0.68804670 |
| 66 | MP0002557_abnormal_social/conspecific_i | 0.68319981 |
| 67 | MP0005166_decreased_susceptibility_to | 0.68134181 |
| 68 | MP0008775_abnormal_heart_ventricle | 0.66962562 |
| 69 | MP0003566_abnormal_cell_adhesion | 0.66303788 |
| 70 | MP0001919_abnormal_reproductive_system | 0.65866384 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 0.65066188 |
| 72 | MP0008260_abnormal_autophagy | 0.64129835 |
| 73 | MP0002064_seizures | 0.63545065 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 0.60630816 |
| 75 | MP0000427_abnormal_hair_cycle | 0.58841221 |
| 76 | MP0001958_emphysema | 0.58328223 |
| 77 | MP0000026_abnormal_inner_ear | 0.58229136 |
| 78 | MP0005083_abnormal_biliary_tract | 0.58148569 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.56320039 |
| 80 | MP0009046_muscle_twitch | 0.55819337 |
| 81 | MP0000767_abnormal_smooth_muscle | 0.55677243 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.55261026 |
| 83 | MP0005171_absent_coat_pigmentation | 0.53611774 |
| 84 | MP0005025_abnormal_response_to | 0.53380875 |
| 85 | MP0003436_decreased_susceptibility_to | 0.51273620 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.50402002 |
| 87 | MP0010155_abnormal_intestine_physiology | 0.48830237 |
| 88 | MP0001177_atelectasis | 0.48575940 |
| 89 | MP0000516_abnormal_urinary_system | 0.47311796 |
| 90 | MP0005367_renal/urinary_system_phenotyp | 0.47311796 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.47285043 |
| 92 | MP0008872_abnormal_physiological_respon | 0.47141175 |
| 93 | MP0002723_abnormal_immune_serum | 0.46967745 |
| 94 | MP0002452_abnormal_antigen_presenting | 0.45369590 |
| 95 | MP0005647_abnormal_sex_gland | 0.45347034 |
| 96 | MP0005535_abnormal_body_temperature | 0.45118935 |
| 97 | MP0003011_delayed_dark_adaptation | 0.45116459 |
| 98 | MP0002063_abnormal_learning/memory/cond | 0.44619046 |
| 99 | MP0001800_abnormal_humoral_immune | 0.44394239 |
| 100 | MP0004133_heterotaxia | 0.43950183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe visual impairment (HP:0001141) | 9.31107779 |
| 2 | Oligodactyly (HP:0012165) | 7.87999310 |
| 3 | Absent hand (HP:0004050) | 7.46898799 |
| 4 | Pendular nystagmus (HP:0012043) | 7.06614548 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 6.43249094 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.60198351 |
| 7 | Increased circulating renin level (HP:0000848) | 5.06738227 |
| 8 | Severe Myopia (HP:0011003) | 4.75175655 |
| 9 | Agitation (HP:0000713) | 4.66739362 |
| 10 | Horizontal nystagmus (HP:0000666) | 3.95058172 |
| 11 | Alveolar cell carcinoma (HP:0006519) | 3.91117040 |
| 12 | Mesangial abnormality (HP:0001966) | 3.91015306 |
| 13 | Hypomagnesemia (HP:0002917) | 3.77606587 |
| 14 | Tetany (HP:0001281) | 3.62937364 |
| 15 | Striae distensae (HP:0001065) | 3.60682700 |
| 16 | Abdominal situs inversus (HP:0003363) | 3.54279286 |
| 17 | Abnormality of abdominal situs (HP:0011620) | 3.54279286 |
| 18 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.51726866 |
| 19 | Hyperphosphatemia (HP:0002905) | 3.41813798 |
| 20 | Resting tremor (HP:0002322) | 3.19734035 |
| 21 | Muscle stiffness (HP:0003552) | 3.16029451 |
| 22 | Hypercortisolism (HP:0001578) | 3.13511254 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.12905070 |
| 24 | Optic neuritis (HP:0100653) | 3.12905070 |
| 25 | Abnormality of magnesium homeostasis (HP:0004921) | 3.00484093 |
| 26 | Mesomelia (HP:0003027) | 2.93722530 |
| 27 | Akinesia (HP:0002304) | 2.76364634 |
| 28 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.75587731 |
| 29 | Orchitis (HP:0100796) | 2.75333471 |
| 30 | Abnormal drinking behavior (HP:0030082) | 2.69910690 |
| 31 | Polydipsia (HP:0001959) | 2.69910690 |
| 32 | Depression (HP:0000716) | 2.68069844 |
| 33 | Metaphyseal irregularity (HP:0003025) | 2.60775912 |
| 34 | Absent toe (HP:0010760) | 2.58151374 |
| 35 | Macular degeneration (HP:0000608) | 2.51806048 |
| 36 | Abnormality of renin-angiotensin system (HP:0000847) | 2.47464555 |
| 37 | Restlessness (HP:0000711) | 2.45579285 |
| 38 | Generalized myoclonic seizures (HP:0002123) | 2.43699599 |
| 39 | Type 2 muscle fiber atrophy (HP:0003554) | 2.35763576 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33344595 |
| 41 | Anxiety (HP:0000739) | 2.29093531 |
| 42 | Incomplete penetrance (HP:0003829) | 2.27034057 |
| 43 | Neonatal respiratory distress (HP:0002643) | 2.26200869 |
| 44 | Basal ganglia calcification (HP:0002135) | 2.25821661 |
| 45 | Erythroderma (HP:0001019) | 2.25229527 |
| 46 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.25190860 |
| 47 | Myositis (HP:0100614) | 2.22460642 |
| 48 | Hypoplasia of the thymus (HP:0000778) | 2.17495814 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 2.08031269 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.04667797 |
| 51 | B lymphocytopenia (HP:0010976) | 2.04667797 |
| 52 | Lack of skin elasticity (HP:0100679) | 2.03996168 |
| 53 | Muscle fiber atrophy (HP:0100295) | 2.01803846 |
| 54 | Split foot (HP:0001839) | 11.5242086 |
| 55 | Oligodactyly (hands) (HP:0001180) | 11.2671677 |
| 56 | Hypophosphatemia (HP:0002148) | 1.99648413 |
| 57 | Reduced antithrombin III activity (HP:0001976) | 1.98279131 |
| 58 | Tachypnea (HP:0002789) | 1.97842471 |
| 59 | Split hand (HP:0001171) | 1.97119539 |
| 60 | Distal lower limb muscle weakness (HP:0009053) | 1.93155223 |
| 61 | Lower limb amyotrophy (HP:0007210) | 1.92628602 |
| 62 | Hyperparathyroidism (HP:0000843) | 1.92318739 |
| 63 | Generalized tonic-clonic seizures (HP:0002069) | 1.90502656 |
| 64 | Neurodegeneration (HP:0002180) | 1.89459725 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 1.88465946 |
| 66 | Fatigable weakness (HP:0003473) | 1.83970927 |
| 67 | Abnormality of the neuromuscular junction (HP:0003398) | 1.83970927 |
| 68 | Focal segmental glomerulosclerosis (HP:0000097) | 1.82188639 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.80918295 |
| 70 | Poor suck (HP:0002033) | 1.80852992 |
| 71 | Intellectual disability, moderate (HP:0002342) | 1.78551000 |
| 72 | Abnormal urine phosphate concentration (HP:0012599) | 1.77331067 |
| 73 | Status epilepticus (HP:0002133) | 1.76322324 |
| 74 | Truncal obesity (HP:0001956) | 1.75866650 |
| 75 | Gangrene (HP:0100758) | 1.74755167 |
| 76 | Abnormal connection of the cardiac segments (HP:0011545) | 1.73964094 |
| 77 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.73964094 |
| 78 | Transposition of the great arteries (HP:0001669) | 1.73964094 |
| 79 | Steatorrhea (HP:0002570) | 1.73506165 |
| 80 | Pancreatitis (HP:0001733) | 1.73386650 |
| 81 | Respiratory distress (HP:0002098) | 1.72305469 |
| 82 | Abnormality of the intrinsic pathway (HP:0010989) | 1.72022550 |
| 83 | Childhood onset (HP:0011463) | 1.68232007 |
| 84 | Eosinophilia (HP:0001880) | 1.68022889 |
| 85 | Keratoconjunctivitis (HP:0001096) | 1.64467379 |
| 86 | Facial cleft (HP:0002006) | 1.63027725 |
| 87 | Conical tooth (HP:0000698) | 1.62700685 |
| 88 | Postural instability (HP:0002172) | 1.61558568 |
| 89 | Hypotension (HP:0002615) | 1.58924680 |
| 90 | Hypercalciuria (HP:0002150) | 1.54791547 |
| 91 | Hypophosphatemic rickets (HP:0004912) | 1.54467854 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 1.53517846 |
| 93 | Polyuria (HP:0000103) | 1.53242647 |
| 94 | Adrenal overactivity (HP:0002717) | 1.52990264 |
| 95 | Abnormal tarsal ossification (HP:0008369) | 1.52457607 |
| 96 | Generalized hypotonia (HP:0001290) | 1.51939643 |
| 97 | Upper limb muscle weakness (HP:0003484) | 1.51641466 |
| 98 | Paresthesia (HP:0003401) | 1.50527055 |
| 99 | Flat face (HP:0012368) | 1.50325528 |
| 100 | Thyroiditis (HP:0100646) | 1.50226896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.69665498 |
| 2 | BLK | 4.99302668 |
| 3 | TNK2 | 3.94913096 |
| 4 | MAP3K14 | 3.74949497 |
| 5 | EIF2AK2 | 3.56315143 |
| 6 | RIPK4 | 3.34159952 |
| 7 | PRKCG | 2.47572113 |
| 8 | BMX | 2.39920976 |
| 9 | TNIK | 2.38187766 |
| 10 | NTRK3 | 2.16610068 |
| 11 | IRAK3 | 2.15901112 |
| 12 | JAK1 | 2.06553592 |
| 13 | PRPF4B | 2.01892852 |
| 14 | BUB1 | 1.88937578 |
| 15 | EPHA2 | 1.76900760 |
| 16 | IRAK1 | 1.62289567 |
| 17 | PRKD3 | 1.60173878 |
| 18 | CSF1R | 1.57190870 |
| 19 | ALK | 1.50061893 |
| 20 | PRKCH | 1.42491747 |
| 21 | TBK1 | 1.32049314 |
| 22 | CAMK1 | 1.28038489 |
| 23 | CAMK4 | 1.27291043 |
| 24 | FES | 1.26839022 |
| 25 | DAPK2 | 1.21221465 |
| 26 | PRKCE | 1.18081591 |
| 27 | IKBKE | 1.15205644 |
| 28 | SYK | 1.13042057 |
| 29 | STK11 | 1.08521198 |
| 30 | SIK2 | 1.05557551 |
| 31 | MKNK2 | 1.01687292 |
| 32 | ITK | 1.00595248 |
| 33 | AKT2 | 0.98364417 |
| 34 | CAMK2A | 0.97719490 |
| 35 | CAMK2G | 0.97102273 |
| 36 | CAMK1G | 0.96876673 |
| 37 | YES1 | 0.92743513 |
| 38 | PRKCQ | 0.85709866 |
| 39 | STK24 | 0.82577371 |
| 40 | PIK3CA | 0.79119921 |
| 41 | NTRK1 | 0.77895402 |
| 42 | EPHA4 | 0.75069319 |
| 43 | CAMK1D | 0.74913994 |
| 44 | PAK3 | 0.71525695 |
| 45 | PRKCD | 0.67483984 |
| 46 | HCK | 0.66851523 |
| 47 | CAMKK1 | 0.66139771 |
| 48 | RPS6KL1 | 0.64470440 |
| 49 | RPS6KC1 | 0.64470440 |
| 50 | LYN | 0.61306488 |
| 51 | PRKCZ | 0.61209654 |
| 52 | SGK2 | 0.61140558 |
| 53 | FGFR4 | 0.60525074 |
| 54 | KIT | 0.60072361 |
| 55 | WNK1 | 0.59976189 |
| 56 | ZAP70 | 0.58507377 |
| 57 | BMPR2 | 0.58405660 |
| 58 | TEC | 0.58404472 |
| 59 | RPS6KA6 | 0.57393514 |
| 60 | CSK | 0.57052354 |
| 61 | LCK | 0.56603431 |
| 62 | FYN | 0.56519415 |
| 63 | TRPM7 | 0.55695361 |
| 64 | INSR | 0.55694246 |
| 65 | MARK1 | 0.55132002 |
| 66 | GRK1 | 0.54017395 |
| 67 | TTN | 0.53524008 |
| 68 | SGK223 | 0.52526653 |
| 69 | SGK494 | 0.52526653 |
| 70 | IKBKB | 0.52488452 |
| 71 | PRKCB | 0.52305173 |
| 72 | FRK | 0.52251648 |
| 73 | MAPK3 | 0.50021556 |
| 74 | SGK1 | 0.48963409 |
| 75 | SRC | 0.48286048 |
| 76 | NTRK2 | 0.47989482 |
| 77 | EIF2AK3 | 0.47907980 |
| 78 | PRKACA | 0.45420304 |
| 79 | JAK2 | 0.44997440 |
| 80 | PRKCA | 0.44915586 |
| 81 | TXK | 0.44523848 |
| 82 | PDK1 | 0.43363050 |
| 83 | RET | 0.41871714 |
| 84 | TYK2 | 0.40534270 |
| 85 | MAP2K6 | 0.40478951 |
| 86 | CLK1 | 0.39632762 |
| 87 | FGR | 0.39281329 |
| 88 | PKN1 | 0.38995051 |
| 89 | PDGFRB | 0.38932086 |
| 90 | FLT3 | 0.36849459 |
| 91 | RPS6KB1 | 0.36428748 |
| 92 | MAP2K7 | 0.35161867 |
| 93 | MAPK7 | 0.33918992 |
| 94 | PKN2 | 0.33514666 |
| 95 | PRKG2 | 0.32878370 |
| 96 | PRKACG | 0.32399270 |
| 97 | MAP2K1 | 0.32186361 |
| 98 | CDK5 | 0.31851741 |
| 99 | MET | 0.30944436 |
| 100 | MINK1 | 0.30250801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 4.44961771 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.96480152 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 2.87609603 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63837732 |
| 5 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.61124030 |
| 6 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.45146558 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.36925616 |
| 8 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.34342729 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.17644379 |
| 10 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.13251911 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10378671 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.07248870 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02642281 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87406472 |
| 15 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.87214045 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.83362963 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.81828681 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.77750344 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.77512957 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40073462 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.34335361 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.30417169 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.29460665 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29366072 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26318096 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21225027 |
| 27 | Melanogenesis_Homo sapiens_hsa04916 | 1.12734388 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11111041 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.07166050 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05196841 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.03754607 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01162789 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00557396 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93309806 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93176693 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92159479 |
| 37 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.87255570 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86988049 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84987828 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84952227 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84680307 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82987319 |
| 43 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82203271 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81808469 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79236288 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78572589 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77976384 |
| 48 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77945783 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77372959 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 0.76848020 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.76699848 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73628044 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72925166 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72780895 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72481714 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71219495 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70590877 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69722192 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67034832 |
| 60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66346164 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65665087 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65462307 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64117635 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63025773 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61489639 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.58822032 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56483510 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.56356377 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53835152 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49761442 |
| 71 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47639586 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47530346 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47468196 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46858069 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46268706 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.45413292 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.45349172 |
| 78 | Axon guidance_Homo sapiens_hsa04360 | 0.44753101 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.42616544 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41676446 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40696135 |
| 82 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38631553 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37685993 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.36911600 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36558766 |
| 86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36363428 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36086092 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.35220350 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33693478 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33138451 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32892908 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.32416051 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32133817 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.32032971 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31157016 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.30310090 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29319415 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.28994350 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28207550 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28148941 |

